(1)
Deferasirox on COVID-19: Safety and Efficacy of Iron-Chelating Therapy. A Multicentric, Randomized, Triple Blinded Study. PPCR 2022, 7 (4), 38-46. https://doi.org/10.21801/ppcrj.2021.74.5.